vs

Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Digital Realty (DLR). Click either name above to swap in a different company.

Digital Realty is the larger business by last-quarter revenue ($1.6B vs $950.5M, roughly 1.7× Astrana Health, Inc.). Digital Realty runs the higher net margin — 6.0% vs 0.7%, a 5.3% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 16.1%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 9.8%).

Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.

Digital Realty is a real estate investment trust that owns, operates and invests in carrier-neutral data centers across the world. The company offers data center, colocation, and interconnection services.

ASTH vs DLR — Head-to-Head

Bigger by revenue
DLR
DLR
1.7× larger
DLR
$1.6B
$950.5M
ASTH
Growing faster (revenue YoY)
ASTH
ASTH
+26.8% gap
ASTH
42.9%
16.1%
DLR
Higher net margin
DLR
DLR
5.3% more per $
DLR
6.0%
0.7%
ASTH
Faster 2-yr revenue CAGR
ASTH
ASTH
Annualised
ASTH
53.3%
9.8%
DLR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASTH
ASTH
DLR
DLR
Revenue
$950.5M
$1.6B
Net Profit
$6.6M
$98.6M
Gross Margin
Operating Margin
1.9%
6.9%
Net Margin
0.7%
6.0%
Revenue YoY
42.9%
16.1%
Net Profit YoY
184.4%
-10.3%
EPS (diluted)
$0.12
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASTH
ASTH
DLR
DLR
Q1 26
$1.6B
Q4 25
$950.5M
$1.6B
Q3 25
$956.0M
$1.6B
Q2 25
$654.8M
$1.5B
Q1 25
$620.4M
$1.4B
Q4 24
$665.2M
$1.4B
Q3 24
$478.7M
$1.4B
Q2 24
$486.3M
$1.4B
Net Profit
ASTH
ASTH
DLR
DLR
Q1 26
$98.6M
Q4 25
$6.6M
$98.6M
Q3 25
$373.0K
$67.8M
Q2 25
$9.4M
$1.0B
Q1 25
$6.7M
$110.0M
Q4 24
$-7.8M
$189.6M
Q3 24
$16.1M
$51.2M
Q2 24
$19.2M
$80.2M
Operating Margin
ASTH
ASTH
DLR
DLR
Q1 26
6.9%
Q4 25
1.9%
6.9%
Q3 25
2.0%
8.8%
Q2 25
3.1%
14.2%
Q1 25
3.3%
13.9%
Q4 24
0.1%
10.1%
Q3 24
5.9%
11.8%
Q2 24
6.2%
0.7%
Net Margin
ASTH
ASTH
DLR
DLR
Q1 26
6.0%
Q4 25
0.7%
6.0%
Q3 25
0.0%
4.3%
Q2 25
1.4%
69.1%
Q1 25
1.1%
7.8%
Q4 24
-1.2%
13.2%
Q3 24
3.4%
3.6%
Q2 24
3.9%
5.9%
EPS (diluted)
ASTH
ASTH
DLR
DLR
Q1 26
$0.22
Q4 25
$0.12
$0.22
Q3 25
$0.01
$0.15
Q2 25
$0.19
$2.94
Q1 25
$0.14
$0.27
Q4 24
$-0.14
$0.50
Q3 24
$0.33
$0.09
Q2 24
$0.40
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASTH
ASTH
DLR
DLR
Cash + ST InvestmentsLiquidity on hand
$429.5M
$3.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$779.3M
$22.9B
Total Assets
$2.2B
$49.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASTH
ASTH
DLR
DLR
Q1 26
$3.5B
Q4 25
$429.5M
$3.5B
Q3 25
$463.4M
$3.3B
Q2 25
$342.1M
$3.6B
Q1 25
$260.9M
$2.3B
Q4 24
$290.8M
$3.9B
Q3 24
$350.3M
$2.2B
Q2 24
$327.7M
$2.3B
Stockholders' Equity
ASTH
ASTH
DLR
DLR
Q1 26
$22.9B
Q4 25
$779.3M
$22.9B
Q3 25
$775.5M
$23.0B
Q2 25
$765.5M
$22.9B
Q1 25
$745.4M
$21.3B
Q4 24
$712.7M
$21.3B
Q3 24
$704.6M
$21.2B
Q2 24
$678.9M
$20.5B
Total Assets
ASTH
ASTH
DLR
DLR
Q1 26
$49.4B
Q4 25
$2.2B
$49.4B
Q3 25
$2.2B
$48.7B
Q2 25
$1.4B
$48.7B
Q1 25
$1.3B
$45.1B
Q4 24
$1.4B
$45.3B
Q3 24
$1.3B
$45.3B
Q2 24
$1.3B
$43.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASTH
ASTH
DLR
DLR
Operating Cash FlowLast quarter
$-2.9M
Free Cash FlowOCF − Capex
$-6.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
-0.44×
TTM Free Cash FlowTrailing 4 quarters
$104.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASTH
ASTH
DLR
DLR
Q1 26
Q4 25
$-2.9M
$719.0M
Q3 25
$10.0M
$652.9M
Q2 25
$90.9M
$641.2M
Q1 25
$16.6M
$399.1M
Q4 24
$-10.9M
$769.5M
Q3 24
$34.0M
$566.5M
Q2 24
$23.2M
$573.2M
Free Cash Flow
ASTH
ASTH
DLR
DLR
Q1 26
Q4 25
$-6.0M
Q3 25
$7.4M
Q2 25
$89.5M
Q1 25
$13.6M
Q4 24
$-13.5M
Q3 24
$31.7M
Q2 24
$20.4M
FCF Margin
ASTH
ASTH
DLR
DLR
Q1 26
Q4 25
-0.6%
Q3 25
0.8%
Q2 25
13.7%
Q1 25
2.2%
Q4 24
-2.0%
Q3 24
6.6%
Q2 24
4.2%
Capex Intensity
ASTH
ASTH
DLR
DLR
Q1 26
Q4 25
0.3%
Q3 25
0.3%
Q2 25
0.2%
Q1 25
0.5%
Q4 24
0.4%
Q3 24
0.5%
Q2 24
0.6%
Cash Conversion
ASTH
ASTH
DLR
DLR
Q1 26
Q4 25
-0.44×
7.29×
Q3 25
26.69×
9.63×
Q2 25
9.65×
0.62×
Q1 25
2.48×
3.63×
Q4 24
4.06×
Q3 24
2.11×
11.07×
Q2 24
1.21×
7.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASTH
ASTH

Medicare$542.4M57%
Commercial$99.1M10%
Care Delivery$92.1M10%
Care Enablement$78.9M8%
Other Third Parties$58.0M6%
Health Care Patient Service$39.8M4%
Health Care Other$25.5M3%
Other$12.1M1%
Management Service$10.3M1%

DLR
DLR

Segment breakdown not available.

Related Comparisons